Adv Efrat Shpizaizen is a partner in the High Tech and Venture Capital department in Amit, Pollak, Matalon & Co.
Efrat is highly experienced in advising technology companies throughout the various stages of their life-cycle and development, from the early stage of ideation through to a successful exit transaction. Efrat’s clients operate in a diverse range of sectors, including, media, telecom, energy, fintech, foodtech, cannabis-tech, life sciences, automation and more.
Efrat represents her clients in an array of corporate and commercial transactions, local and international, including, M&As, equity and debt financings, strategic partnerships and collaborations, research & development agreements, licensing agreements, manufacturing and distribution agreements and more. Efrat also advises her clients in relation to their ongoing business and commercial operations.
Efrat’s practice includes the representation of private equity funds through the process of the fund’s formation and during its life-cycle. In this respect, Efrat advises and handles the funds’ capital raising efforts as well as the formation of dedicated investment vehicles.
Efrat is frequently involved in structuring and negotiating complex international collaborations and strategic partnerships through special purpose vehicles and contractual legal constructions. As an example, Efrat represents Israeli companies in their efforts of expansion into new markets through strategic partnerships with local entities, involving R&D projects, project management, protection of IP, licensing arrangements and commercialization post development.
Some of the more recent transactions and projects Efrat handled and advised on:
- Representation of Aleph Farms, which operates in the field of cultured meat, in a US$105 million equity financing led by L Catterton, the world’s larges private equity fund in the consumerism sector and, DisruptAD, one of the largest investment platforms in the Middle East.
From the media: “Aleph Farms completes $105 million Series B round”, CTech Calcalist, July 7, 2021.
- Representation of Aquarius Engines, the innovative Israeli start-up, in a strategic partnership agreement with Nokia Global, at an estimated transaction valuation of US$280 million.
From the media: “A quarter of a billion Euros: Israeli Aquarius signed an agreement with Nokia”, The Marker (Hebrew), June 1, 2020.
- Representation of Panaxia Pharmaceutical Industries in a cooperation agreement with European Neuraxpharm.
From the media: “Panaxia goes up by 5% after signing a definitive agreement with Neuraxpharm”, The Marker (Hebrew), July 19, 2020.
- Representation of StageOne Ventures in the closing of its fourth fund of $150 million, and, in parallel, an additional $85 million to be used for follow-on investments.
From the media: “StageOne Ventures raises $235 million for fourth fund”, CTech Calcalist, January 4, 2022.
- Representation of Liquidity Capital, Israeli fintech and fund management company from the Meitav-Dash Group, in an investment transaction, with the participation of U.S. VC Spark Capital, and Japanese Innovation Fund – MUIP from the Mitsubishi Group.
From the media: “Foreign funds will invest US$20 million in Liquidity Capital; Meitav Dash will lose control”, Calcalist (Hebrew), October 22, 2020.
- Representation of Liquidity Capital in transactions to acquire future revenue from a long line of companies, e.g., Infinidat, Xjet, SweetInn, EZBob and more, valued in hundreds of millions of US dollars.
- Representation of Zifroni Chemicals and its shareholders in a transaction for the acquisition of its shares by IMCD, a leading Dutch international corporation.
See IMCD press release here.
Prior to joining the firm, Ms. Shpizaizen worked as an associate in the High Tech and Venture Capital department of Moshe Nisim, Rinkov, Senderovitch law firm.
Efrat joined the firm in 2015 and was promoted to partner in 2020.
